¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"y"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
9
ÄÚµå
¿µ¹®
ÇѱÛ
Y46.7
Antiparkinsonism drugs
ÇׯÄŲ½¼Á¦ ¾à¹°
Y56.1
Antipruritics
°¡·Á¿ò¾à(Ç×°¡·Á¿òÁ¦)
Y45.4
Antirheumatics
Ç×·ù¸¶Æ¼½ºÁ¦
Y46.8
Antispasticity drugs
Ç×°æ·Ã¼º ¾à¹°
Y44.4
Antithrombotic drugs [platelet-aggregation inhibitors]
Ç×Ç÷ÀüÁ¦[Ç÷¼ÒÆÇ ÀÀÁý ¾ïÁ¦Á¦]
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½